• No results found

Hepatitis C RNA-polymerase – relevant drug target

N/A
N/A
Protected

Academic year: 2022

Share "Hepatitis C RNA-polymerase – relevant drug target"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Hepatitis C RNA-polymerase – relevant drug target

Eldar Abdurakhmanov

Hepatitis C virus is a human pathogen that causes chronic hepatitis, cirrhosis and liver cancer.

The high prevalence of the virus, absence of a vaccine and inefficient therapy are currently big medical concerns. The virus is transmitted by blood-to-blood routes, for example, intravenous drug use, unsafe medical intervention and blood transmission. The infection is usually asymptomatic, which makes it difficult to diagnose at an early stage

The RNA-dependent RNA-polymerase NS5B is an enzyme that copies the genetic material of the virus and thus plays a very important role in Hepatitis C virus propagation and is one of the main drug targets and of major interest for drug discovery. Therefore the project aimed to isolate, purify and characterize the viral polymerase for drug discovery by using surface plasmon resonance technology.

Biacore surface plasmon resonance biosensor technology is a powerful tool to monitor the interactions of molecules in real time and to determine necessary interaction characteristics.

The technology is applied in various fields such as food analysis, life science research, in drug discovery, and others.

Truncated forms of NS5B with different affinity tags were produced in bacterial cells and purified with various protein separation techniques, according to the fused affinity tags. The affinity tags are short amino acid sequences that help to capture protein during purification procedure and facilitate the attachment of the protein on a biosensor chip. To obtain the full- length variant of NS5B, a DNA construct for production of the NS5B polymerase in insect cells was generated. Since it was important to know if the produced NS5B was functional, an activity assay was established. The assay proved that the NS5B protein was active and capable of synthesizing RNA. To further characterize the NS5B polymerase, it was

immobilized on a biosensor chip surface and interaction experiments with a known inhibitor of NS5B and RNA were performed using the Biacore system. An enzyme inhibitor is a molecule that blocks the enzyme activity and thus can kill the pathogen. Many drugs in fact are enzyme inhibitors. The biosensor experiments showed that NS5B interacts with its inhibitor and preliminary kinetic parameters of this interaction were determined.

Degree project in applied biotechnology

Examensarbete i biologi/tillämpad bioteknologi, 30hp, Uppsala universitet, vår 2010

Biology Education Centre and Department of Biochemistry and Organic Chemistry, Uppsala University

Supervisors: Prof. Helena Danielson and Johan Winquist

References

Related documents

Here we present evidence: (i) that both DksA and ppGpp are required for in vivo s 54 transcription even though they do not have any major direct effects on s 54 transcription

To clarify whether baseline intrahepatic IP-10 mRNA expression reflects baseline plasma IP-10 levels in predicting first phase viral decline and sustained

IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV.. Lagging M,

Hepatoma cell lines and PHH have also been used to study how the IFNL subtypes differ in their ability to limit viral infections; IFNL3 and IFNL4 induce the same set of ISGs in

[r]

INDIA-provet med 1,5mM MgCl 2 ledde till att de utspädda proverna visade amplifieringar av både primrar (HEVTAGF1 och HEVTAGR1) samt ett band sågs i provet utan någon

x Study the association between HCV infection and primary liver cancer (PLC), and to estimate the absolute risk for PLC, in all diagnosed HCV- infected individuals in Sweden

Hepatitis B virus RN A in serum and li ver tissue - quantification using digital PCR | Kasthuri Pr akash SAHLGRENSKA ACADEMY. INSTITUTE